Brief: Cancer Genetics CFO Glenn Miles To Cease Employment As CFO Effective Nov 16, 2020
Oct 19 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS - ON OCT 16, CO & CFO GLENN MILES,
MUTUALLY
DETERMINED MILES WOULD CEASE HIS EMPLOYMENT AS CFO EFFECTIVE NOV
16, 2020
Source text: (https://bit.ly/2ICc8qS)
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration